Engineered Gut Bacteria Therapy Emerges as Scalable Potential Alternative to Fecal Microbiota Transplants Following Clinical Trial
Researchers at the Icahn School of Medicine at Mount Sinai have developed a new manufacturing platform for producing targeted mixtures of beneficial gut bacteria, an approach that could help expand…
Read More